Lactiplantibacillus plantarum 299v (LP299V®) is the most clinically documented L. plantarum strain in the world. LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within areas reaching from inflammation to metabolic health. The extensive documentation and clinical evidence make this strain unique and ideal for building consumer loyalty.
Probi Digestis® is based on the LP299V® strain, understand the probiotic mode of action in this video:
LP299V® is a registered trademark of Probi AB.
The strain is patent-protected and approved for a wide range of indications and applications worldwide.